Prince Pharmaceutical Co., Ltd. (TPEX:6935)
Taiwan · Delayed Price · Currency is TWD 28.45
+0.10 (0.35%)
Sep 8, 2026, 1:41 PM CST
Prince Pharmaceutical Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 224.85 | 152.62 | 102.8 | 122.57 | 71.96 | 72.5 |
Cash & Short-Term Investments | 224.85 | 152.62 | 102.8 | 122.57 | 71.96 | 72.5 |
Cash Growth | 192.57% | 48.46% | -16.12% | 70.33% | -0.74% | 27.02% |
Accounts Receivable | 156.59 | 197.13 | 116.63 | 108.7 | 72.65 | 62.44 |
Receivables | 156.59 | 197.13 | 116.63 | 108.7 | 72.65 | 62.44 |
Inventory | 306.92 | 207.58 | 141.47 | 142.12 | 149.86 | 125.44 |
Prepaid Expenses | - | 2.76 | - | - | - | - |
Other Current Assets | 5.71 | 0.81 | 4.22 | 18.01 | 7.22 | 14.91 |
Total Current Assets | 694.07 | 560.89 | 365.13 | 391.39 | 301.68 | 275.29 |
Property, Plant & Equipment | 917.68 | 932.72 | 973.6 | 999.83 | 969.34 | 979.79 |
Other Intangible Assets | 0.43 | 0.5 | 0.45 | 1.3 | 1.51 | 2.02 |
Long-Term Deferred Tax Assets | 2.75 | 2.75 | 2.29 | 3.83 | 3.26 | 15.85 |
Other Long-Term Assets | 7.45 | 6.62 | 6.78 | 14.59 | 28.49 | 17.69 |
Total Assets | 1,622 | 1,503 | 1,348 | 1,411 | 1,304 | 1,291 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 236.72 | 163.24 | 108.06 | 84.83 | 55.37 | 68.46 |
Accrued Expenses | - | 54.08 | - | - | - | - |
Short-Term Debt | 30 | 30 | 30 | 30 | 30 | 60 |
Current Portion of Long-Term Debt | 33.54 | 33.14 | 32.35 | 31.76 | 31.43 | 16.91 |
Current Portion of Leases | 5.78 | 4.93 | 8.07 | 5.01 | 6.97 | 3.19 |
Current Income Taxes Payable | 12.89 | 8.84 | - | 4.35 | - | - |
Current Unearned Revenue | 3.19 | 4.3 | 5.45 | 2.62 | 14.78 | 10.91 |
Other Current Liabilities | 88.8 | 11.38 | 50.79 | 53.38 | 51.61 | 41.67 |
Total Current Liabilities | 410.93 | 309.91 | 234.71 | 211.94 | 190.16 | 201.14 |
Long-Term Debt | 217.27 | 234.13 | 267.27 | 299.49 | 330.92 | 362.06 |
Long-Term Leases | 121.7 | 119.83 | 123.11 | 124.1 | 123.78 | 123.83 |
Long-Term Deferred Tax Liabilities | 0.95 | 0.95 | 1.1 | 0.93 | 1.05 | 0.74 |
Total Liabilities | 750.84 | 664.81 | 626.19 | 636.47 | 645.91 | 687.77 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 374.1 | 374.1 | 366.05 | 361.93 | 331.93 | 331.93 |
Additional Paid-In Capital | 368.67 | 368.67 | 363.93 | 348.49 | 282.22 | 279.29 |
Retained Earnings | 128.77 | 95.91 | -7.92 | 53.81 | 44.23 | -8.36 |
Comprehensive Income & Other | - | - | - | 10.24 | - | - |
Shareholders' Equity | 871.54 | 838.68 | 722.06 | 774.47 | 658.38 | 602.87 |
Total Liabilities & Equity | 1,622 | 1,503 | 1,348 | 1,411 | 1,304 | 1,291 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 408.28 | 422.03 | 460.8 | 490.36 | 523.11 | 565.99 |
Net Cash (Debt) | -183.43 | -269.41 | -357.99 | -367.79 | -451.15 | -493.49 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -4.90 | -7.29 | -9.79 | -10.06 | -13.54 | -14.87 |
Filing Date Shares Outstanding | 37.41 | 36.61 | 36.61 | 36.19 | 33.19 | 33.19 |
Total Common Shares Outstanding | 37.41 | 36.61 | 36.61 | 36.19 | 33.19 | 33.19 |
Working Capital | 283.15 | 250.98 | 130.42 | 179.45 | 111.52 | 74.15 |
Book Value Per Share | 23.30 | 22.91 | 19.73 | 21.40 | 19.83 | 18.16 |
Tangible Book Value | 871.12 | 838.17 | 721.61 | 773.16 | 656.86 | 600.85 |
Tangible Book Value Per Share | 23.29 | 22.90 | 19.71 | 21.36 | 19.79 | 18.10 |
Land | 102.92 | 102.92 | 102.92 | 102.92 | 102.92 | 102.92 |
Buildings | 593.57 | 593.57 | 580.78 | 580.78 | 578.84 | 578.62 |
Machinery | 462.23 | 462 | 462.94 | 441.82 | 365.91 | 336.1 |
Construction In Progress | 7.91 | - | - | - | - | - |